Teva Plans Buyback

$600 million worth.
Author:
Publish date:

Teva

(TEVA) - Get Report

plans a buyback of $600 million in stock.

The Israel-based pharmaceuticals company's shares were down $1.20, or 3.6%, at $32.10 Tuesday.

This story was created through a joint venture between TheStreet.com and IRIS.